Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting tumor cells by enhancing radiation sensitivity.

W Gillies McKenna1, Ruth J Muschel

  • 1Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Genes, Chromosomes & Cancer
|October 21, 2003
PubMed
Summary

Targeting RAS and PI3 kinase pathways can enhance cancer radiation therapy. Inhibiting these pathways sensitizes tumors with mutations, improving treatment efficacy without harming normal tissues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth.

Cancer cell·2026
Same author

Correction to: Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response.

Cancer & metabolism·2025
Same author

In Vivo PET Detection of Lung Micrometastasis in Mice by Targeting Endothelial VCAM-1 Using a Dual-Contrast PET/MRI Probe.

International journal of molecular sciences·2024
Same author

Enhanced perfusion following exposure to radiotherapy: A theoretical investigation.

PLoS computational biology·2024
Same author

Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response.

Cancer & metabolism·2024
Same author

Evolving polarisation of infiltrating and alveolar macrophages in the lung during metastatic progression of melanoma suggests CCR1 as a therapeutic target.

Oncogene·2022

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiation Oncology

Background:

  • Cancer development is linked to accumulated mutations, as proposed by Al Knudson.
  • Targeting cancer-specific mutations aims to enhance therapy while sparing normal tissues.
  • Activated RAS oncogene expression confers radioresistance, while its inhibition increases radiosensitivity.

Purpose of the Study:

  • To investigate the potential of sensitizing RAS-mutated tumors to radiation therapy.
  • To identify downstream effectors of RAS responsible for altered radiosensitivity.
  • To explore upstream pathways like EGFR and PTEN as potential targets for radiosensitization.

Main Methods:

  • Studied the effect of RAS oncogene activation and inhibition on cellular radiosensitivity.

Related Experiment Videos

  • Investigated the role of phosphoinositide-3-kinase (PI3 kinase) in mediating radiation resistance.
  • Utilized immunohistochemical staining for phosphorylated AKT to identify active PI3 kinase signaling.
  • Examined the role of Epidermal Growth Factor Receptor (EGFR) and PTEN in radiation resistance pathways.

    • Main Results:

    • Inhibition of RAS increased the radiosensitivity of cells with activated RAS.
    • Blocking PI3 kinase enhanced radiation response in cells actively signaling through this pathway.
    • Active PI3 kinase signaling, identified by phosphorylated AKT, correlated with treatment failure.
    • EGFR and PTEN were identified as regulators of the PI3 kinase pathway involved in radiation resistance.

    Conclusions:

    • Targeting RAS and PI3 kinase pathways offers a strategy to enhance tumor radiosensitivity.
    • Identifying active signaling pathways can help select patients likely to respond to radiation.
    • Molecular-based radiosensitization protocols targeting EGFR, RAS, and PTEN may improve local control in resistant tumors.